14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 20 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of MRNS
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Volatile ride for Marinus Pharmaceuticals stock price on Tuesday moving between $1.11 and $1.65
(Updated on Apr 16, 2024)

Sell candidate since Apr 05, 2024 Loss -84.62% PDF

The Marinus Pharmaceuticals stock price fell by -7.69% on the last day (Tuesday, 16th Apr 2024) from $1.30 to $1.20. It has now fallen 5 days in a row. During the last trading day the stock fluctuated 48.65% from a day low at $1.11 to a day high of $1.65. The price has fallen in 8 of the last 10 days and is down by -86.47% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -13 million shares and in total, 22 million shares were bought and sold for approximately $26.26 million.

The stock has broken the wide and falling short-term trend down. Firstly a stronger fallrate is indicated, but false breaks and "sell-off" may occur. However, a further fall is realistic and any reactions back to the breaking point ($7.15) are considered to be a "second chance" to get out. According to the fan-theory $6.09 will represent the new bottom line of the next trend, but it is far too early to say this for certain.

Check out how to make money doing surveys! Ad

MRNS Signals & Forecast

There are few to no technical positive signals at the moment. The Marinus Pharmaceuticals stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $6.09 and $8.48. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, April 09, 2024, and so far it has fallen -85.68%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Marinus Pharmaceuticals stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.540 between high and low, or 48.65%. For the last week, the stock has had daily average volatility of 24.26%.

Marinus Pharmaceuticals is oversold on RSI14 (9). Some stocks may fall long and hard while being oversold on RSI, but stocks that are heavily oversold on RSI often pose good re-bounce chance and played well it can be a buy candidate.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (MRNS) For The Upcoming Trading Day Of Wednesday 17th

For the upcoming trading day on Wednesday, 17th we expect Marinus Pharmaceuticals to open at $1.32, and during the day (based on 14 day Average True Range), to move between $0.268 and $2.13, which gives a possible trading interval of +/-$0.93 (+/-77.63%) up or down from last closing price. If Marinus Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 155.26% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $1.30, some $0.100 (8.33%) from the current price of $1.20, our system finds the risk reward not very attractive.

Is Marinus Pharmaceuticals stock A Buy?

Marinus Pharmaceuticals holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -8.563 Strong Sell Candidate Unchanged

Predicted Opening Price for Marinus Pharmaceuticals of Wednesday, April 17, 2024

Fair opening price April 17, 2024 Current price
$1.32 ( 10.00%) $1.20

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for MRNS

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.86 55.00 %
R2 1.65 37.81 %
R1 1.53 27.19 %
Current price: 1.20
Support S1 1.11 -7.19 %
S2 0.99 -17.81 %
S3 0.780 -35.00 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 0 .
R1 1.30 8.33 %
Current price 1.20
Support S1 0 .
S2 0 .
S3 0 .

FAQ

What is the symbol for Marinus Pharmaceuticals Stock and on which exchange is it traded?
The symbol for Marinus Pharmaceuticals is MRNS and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Marinus Pharmaceuticals Stock?
Marinus Pharmaceuticals holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Marinus Pharmaceuticals Stock?
Marinus Pharmaceuticals Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Marinus Pharmaceuticals Stock.

What's the current price of Marinus Pharmaceuticals Stock?
As of the end of day on the 2024-04-16, the price of an Marinus Pharmaceuticals (MRNS) share was $1.20.

What is the 52-week high and low for Marinus Pharmaceuticals Stock?
The 52-week high for Marinus Pharmaceuticals Stock is $11.26 and the 52-week low is $1.11.

What is the market capitalization of Marinus Pharmaceuticals Stock?
As of the 2024-04-16, the market capitalization of Marinus Pharmaceuticals is 65.571M.

When is the next earnings date for Marinus Pharmaceuticals?
The upcoming earnings date for Marinus Pharmaceuticals is May 09, 2024.
Click to get the best stock tips daily for free!

About Marinus Pharmaceuticals

Marinus Pharmaceuticals Marinus Pharmaceuticals, Inc., a pharmaceutical company, focuses on development and commercialization of products for patients suffering from rare genetic epilepsies and other seizure disorders. It offers ZTALMY, an oral suspension for the treatment of seizures associated with cyclin-dependent kinase-like 5 deficiency disorder for adult and pediatric patient populations in acute and chronic care, and in-patient and self-administered settings. The... MRNS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT